IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn’s disease
Clinical and Experimental Immunology · 2024
DOI: 10.1093/cei/uxad092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2024. Verfasst von Jakob Benedict Seidelin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Medical Section, Herlev Hospital, University of Copenhagen, Denmark. Hauptthemen laut MEDLINE: Crohn Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ontario Institute for Cancer Research, National Institute for Health Research.
Abstract (Originalsprache)
Innate immune activity fuels intestinal inflammation in Crohn’s disease (CD), an inflammatory bowel disease. Identification and targeting of new molecular regulators of the innate activity are warranted to control the disease. Inhibitor of apoptosis proteins (IAPs) regulate both cell survival and inflammatory signaling. We investigated the effects of IAP inhibition by second mitochondria-derived activator of caspases (SMAC) mimetics (SMs) on innate responses and cell death to pathogen-associated molecular patterns in peripheral blood mononuclear cells (PBMCs) and monocytes. IAPs inhibited lipopolysaccharide (LPS)-induced expression of proinflammatory interleukin (IL)-1β, IL-6. Likewise, LPS (but not muramyl dipeptide or Escherichia coli) induced TNF-α was inhibited in CD and control PBMCs. The SM effect was partially reversed by inhibition of receptor-interacting serine/threonine-protein kinase 1 (RIPK1). The effect was mainly cell death independent. Thus, IAP inhibition by SMs leads to reduced production of proinflammatory cytokines and may be considered in the efforts to develop new therapeutic strategies to control CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Medical Section, Herlev Hospital, University of Copenhagen, Denmark.
- Department of Oncology, Center for Cancer Immune Therapy, Herlev Hospital, University of Copenhagen, Denmark.
- Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
- Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Canada.
ORCID-Profile: Jakob Benedict Seidelin
Förderung
- Ontario Institute for Cancer Research
- National Institute for Health Research
Zitieren
APA
Seidelin, J. B., Jensen, S., Hansen, M., de Carvalho Bronze, M. R., Cuchet-Lourenҫo, D., Nejentsev, S., LaCasse, E. C., & Nielsen, O. H. (2024). IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn’s disease. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxad092
Vancouver
Seidelin JB, Jensen S, Hansen M, de Carvalho Bronze MR, Cuchet-Lourenҫo D, Nejentsev S, et al. IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn’s disease. Clinical and Experimental Immunology. 2024. doi:10.1093/cei/uxad092
BibTeX
@article{Seidelin2024,
author = {Seidelin, Jakob Benedict and Jensen, Simone and Hansen, Morten and de Carvalho Bronze, Mariana Rodrigues and Cuchet-Lourenҫo, Delphine and Nejentsev, Sergey and LaCasse, Eric Charles and Nielsen, Ole Haagen},
title = {IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn’s disease},
journal = {Clinical and Experimental Immunology},
year = {2024},
doi = {10.1093/cei/uxad092}
}
EUVIMED